Hi,

How about a rule to prevent PSA on females but then provide a warning that if request is genuine, you need to use test code psax or some other code?

Same approach could then be used on male ca125 requests.

The approach would require that the request has something saying this request is from a transgendered individual e.g. In clinical details or the electronic record for the patient has a note saying patient is trans.

Danny

On 25 Feb 2016, at 08:51, Karen Mitchell <[log in to unmask]> wrote:

Dear collective

 

In order to stop inappropriate requests for tumour markers e.g. PSA and CA125, these are restricted on our requesting system by gender.

 

Has anyone found a good solution to allow clinicians to request these on transgender patients, where the sex has been changed on the PAS/LIMS and therefore blocks the User from requesting the test?

 

I am keen not to discriminate against this subset of patients, but also reluctant to lift the block and potentially allow the clinicians to request ALL tumour markers even when irrelevant!

 

Any suggestions welcomed

 

Karen

 

Dr Karen Mitchell

Consultant Chemical Pathologist, Clinical Lead for Biochemistry & POCT

Calderdale & Huddersfield NHS Foundation Trust

 

[log in to unmask]

 





Disclaimer: This is an e-mail from Calderdale and Huddersfield NHS Foundation Trust (the Trust). This message and any files transmitted with it are confidential. If you are not the intended recipient any reading, printing, storage, disclosure, copying or any other action taken in respect of the e-mail is prohibited and may be unlawful. If you have received this message in error, please notify the sender immediately by using the reply function and then delete what you have received. The Trust accepts no responsibility for any changes made to this message after it has been sent by the original author. The views or opinions contained herein do not necessarily represent the views of the Trust. This e-mail or any of its attachments may contain data that falls within the scope of the Data Protection Acts. You must ensure that any handling or processing of such data by you is fully compliant with the terms and provisions of the Data Protection Act 1984 and 1998. Please note that as the sender of this email is a Public Authority, the contents of any email received in response, even if marked confidential, may be disclosed in accordance with the Freedom of Information Act 2000 unless legally exempt.
------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/
------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/